- Founded
- 2004
- Status
- IPO
- LSVP Investment
- 2009
- Stage Invested
- Series B
Natera develops and commercializes non-invasive methods for analyzing DNA to build solutions for personalizing cancer care management, assessing the health of transplant patients and for planning a family.